427 Efficacy and safety of AK112, an anti-PD-1/VEGF-A bispecific antibody, in patients with platinum-resistant/refractory epithelial ovarian cancer in a Phase 1 study

Autor: Yu Xia, Charlotte Lemech, Xiaoping Jin, Jermaine Coward, Anna Mislang, Baiyong Li, Kon Yew Kwek, Yiting Zhou, Max Wang
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Druh dokumentu: article
ISSN: 2051-1426
DOI: 10.1136/jitc-2021-SITC2021.427
Databáze: Directory of Open Access Journals